Home Asia Pacific Asia Pacific: Chr. Hansen receives Korea’s approval on probiotic health claim

Asia Pacific: Chr. Hansen receives Korea’s approval on probiotic health claim

Chr. Hansen’s health claim application related to the probiotic concept Urex, which contains the company’s Probio-Tec strains RC-14 and GR-1, has been reviewed and approved by the Korean Ministry of Food & Drug Safety (MFDS).

Urex is a dietary supplement that can help maintain a normal vaginal microbiota.

Korean manufacturers using the ingredient may use the health claim Urex can help vaginal health by increasing lactic acid bacteria” on product packaging and in promotion material.

“Urex is the first and only probiotic product with an approved health claim within vaginal health in Korea,” says Lasse Nagell, sales and marketing VP, human health and nutrition.

“Chr. Hansen is spending significant resources on securing official validation of the scientific documentation behind our probiotics these years,” says senior manager Charlotte Hemmingsen, human health and nutrition product registration and documentation.

“The Korean MFDS’s recognition of the documented health benefits of RC-14 and GR-1 works as motivational tailwind in this process. We have been working on the dossier since mid-2013 and it was submitted in January 2014.”

Previous articleAmericas: Cargill buys ADM’s chocolate business, six facilities in Europe, US
Next articleEurope: BASF launches new claim, online discussion platform to celebrate 150 years in 2015